Office of National Drug Control Policy – The White House (2024)

The Office of National Drug Control Policy (ONDCP) is a component of the Executive Office of the President which works to reduce drug use and its consequences by leading and coordinating the development, implementation, and assessment of U.S. drug policy. In addition to its vital ongoing work, ONDCP also provided administrative and financial support to the President’s Commission on Combating Drug Addiction and the Opioid Crisis, established by Executive Order on March 29, 2017 by President Donald J. Trump.

Established in 1988, ONDCP coordinates the federal government’s anti-drug efforts by:

1. Developing a comprehensive National Drug Control Strategy which aims to reduce substance use through public health and public safety measures;
2. Funding and coordinating the activities of law enforcement, community-based coalitions, and other actors working on the ground to combat substance misuse; and
3. Coordinating the activities and related funding of sixteen Federal government agencies and departments to reduce the availability of and the demand for illicit substances.

While ONDCP works broadly on substance misuse, it is focused on the country’s ongoing Opioid Crisis which is caused by the misuse of prescription drugs, heroin, and synthetic opioids like fentanyl.